Published: May 21, 2021 By Alex Keown
Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers.
AavantiBio – Jessie Hanrahan was named chief regulatory officer of AavantiBio. Hanrahan will oversee global regulatory affairs for AavantiBio’s diversified pipeline of gene therapy programs targeting rare diseases with significant unmet medical needs. Most recently, she was Vice President of Regulatory Science at bluebird bio, Inc. Prior to bluebird bio, Hanrahan held positions of increasing responsibility at Genzyme Corp. where she worked across the oncology, multiple sclerosis and rare disease therapeutic areas. Earlier in her career, Hanrahan worked at Boston Scientific Corporation.
Rain Therapeutics Appoints Robert Doebele, M D , Ph D as President Dr Doebele, Rain co-founder, will continue to serve as chief scientific officer
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Obituary: Peter B. Lyons Feb. 23, 1943 – April 29, 2021
Feb. 23, 1943 – April 29, 2021
Peter B. Lyons passed away in Golden, Colorado on Friday, April 29, 2021, following a yearlong battle with cancer. Pete’s partner Peggy Lyon-Bull and his sons Daniel, David and Michael were able to join him at his side in his final hours. He leaves behind a legacy of dedication to his family, to the scientific community and to the nation for a life spent in public service.
Pete was born to Leland and Rita (nee Horblit) Lyons in Hammond Indiana, in 1943. Although born in the midwest, he spent his childhood in Boulder City, Nevada, just outside of Las Vegas, Nevada. During his time in Nevada, he developed a passion for the geology and topography of the American southwest. He was a standout student at the small high school and also excelled as a tennis player in the then sparsely populated state. He went on to become Nevada state champion in tennis while in high school. He later joked that th
CU Cancer Center researchers receive PRCRP grant to investigate metastasis
Two members of the University of Colorado Cancer Center have received prestigious Idea Awards from the U.S. Department of Defense s Peer Reviewed Cancer Research Program (PRCRP).
Founded in 2009, the PRCRP funds cancer research to support service members, their families, and the American public. Since members of the military are exposed to hazardous environments due to the nature of their service and are at risk for the development of many types of cancers, the PRCRP s mission is to promote high-impact research for cancer prevention, detection, treatment, and survivorship.
CU Cancer Center mentored member Masanori Hayashi, MD, a pediatric oncologist at Children s Hospital Colorado, received a PRCRP grant for his investigation into Ewing sarcoma, a cancer that affects children and young adults. Seventy percent of Ewing sarcoma patients respond well to a combination of chemotherapy and surgery, but 30% of pat